MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    NEURONAL NETWORK UNDERLYING DYSPHAGIA IN PARKINSON’S DISEASE

    S. Polychronis, G. Pagano, VC. Suarez Contreras, T. Yousaf, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate whether chewing and swallowing difficulties are associated with changes in cortical thickness. Background: Chewing and swallowing difficulties are a common…
  • 2019 International Congress

    Are there associations between altered brain connectivity and dopaminergic medication in Parkinson’s disease patients with freezing of gait?

    A. Potvin-Desrochers, A. Atri, C. Paquette (Montreal, QC, Canada)

    Objective: The purpose of this study is to assess how brain connectivity is altered in Parkinson’s disease (PD) patients with freezing of gait (FOG), and…
  • 2019 International Congress

    Freezing of gait in Parkinson’s disease: a review of current neuroimaging evidence for the development of effective therapies

    A. Potvin-Desrochers, C. Paquette (Montreal, QC, Canada)

    Objective: The objective of this review is to summarize the results of brain imaging studies assessing freezing of gait (FOG) and to provide new ideas…
  • 2019 International Congress

    Progression of dopaminergic and serotonergic dysfunction related to motor and nonmotor manifestations in apathetic and non-apathetic parkinsonian patients: a 4-year longitudinal double-tracer PET study

    S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)

    Objective: To investigate the progression of dopaminergic and serotonergic dysfunction and their relation to motor and nonmotor impairment in parkinsonian patients with or without apathy,…
  • 2019 International Congress

    Visual subnetwork dysfunction in Parkinson’s patients with primary visual hallucinations

    S. Rane, A. Lenka, S. Prasad, J. Saini, M. Ingalhalikar, P. Pal (Seatle, WA, USA)

    Objective: To evaluate impairments in the visual subnetwork in Parkinson’s disease (PD) patients with psychosis using BOLD fMRI Background: Psychosis occurs in 20-70% of patients…
  • 2019 International Congress

    Correlating subcortical structure and function in idiopathic Parkinson’s disease: A cross-sectional morphometric and [18F]-DOPA PET study

    M. Rolinski, V. Sossi, A. Stoessl, C. Marshall, S. Gill, P. Clatworthy, A. Whone (Bristol, United Kingdom)

    Objective: To investigate whether the local geometric changes in the subcortical structures of patients with idiopathic Parkinson’s disease correlate with dopaminergic terminal functional integrity within…
  • 2019 International Congress

    Could we optimize the stimulation parameters setting of directional leads with a patient-specific imaging software in implanted parkinsonian patients?

    AS. Rolland, N. Carriere, G. Touzet, L. Defebvre, N. Reyns, D. Devos, C. Moreau (Lille Cedex, France)

    Objective: Deep brain stimulation in the subthalamic nucleus (STN) is routinely proposed to parkinsonian patients. Introduction of directional leads offer more flexibility for programming but…
  • 2019 International Congress

    In vivo increased striatal iron deposition in Parkinson’s Disease Dementia and Dementia with Lewy Body

    S. Rota, T. Yousaf, H. Wilson, G. Dervenoulas, G. Pagano, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: To evaluate iron deposition with susceptibility weighted imaging (SWI) MRI in the basal ganglia of patients affected by Parkinson’s Disease Dementia (PDD) and Dementia…
  • 2019 International Congress

    Potential involvement of the caudate nucleus in GBA-associated Parkinson’s disease

    MC. Ruppert, A. Greuel, M. Tahmasian, F. Maier, T. van Eimeren, K. Lohmann, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)

    Objective: Multimodal functional assessment of striatocortical loop integrity in Parkinson’s Disease (PD) patients with and without GBA variants Background: Biallelic GBA mutations provoke the lysosomal…
  • 2019 International Congress

    Micro structural Changes in Substantia Nigra are associated with Severity of Parkinson’s Disease.

    A. Safai, S. Rane, S. Prasad, J. Saini, P. Pal, M. Ingalhalikar (Pune, India)

    Objective: The aim of this study was to apply diffusion tensor imaging (DTI) to evaluate atrophy of the Substantia Nigra pars compacta (SNc), the pathological…
  • « Previous Page
  • 1
  • …
  • 1191
  • 1192
  • 1193
  • 1194
  • 1195
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley